AREX Capital Management LP Buys New Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

AREX Capital Management LP bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 90,000 shares of the medical instruments supplier's stock, valued at approximately $1,708,000. DENTSPLY SIRONA accounts for about 2.4% of AREX Capital Management LP's investment portfolio, making the stock its 9th biggest holding.

Other hedge funds also recently made changes to their positions in the company. Treasurer of the State of North Carolina boosted its holdings in shares of DENTSPLY SIRONA by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after purchasing an additional 560 shares during the last quarter. UMB Bank n.a. boosted its stake in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 564 shares during the period. Blue Trust Inc. lifted its stake in DENTSPLY SIRONA by 10.9% in the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock worth $137,000 after purchasing an additional 707 shares during the last quarter. Quarry LP grew its stake in shares of DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after buying an additional 780 shares during the last quarter. Finally, Federated Hermes Inc. boosted its holdings in DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after acquiring an additional 915 shares during the period. 95.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on XRAY. StockNews.com cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Robert W. Baird cut their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Mizuho cut their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Finally, Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target for the company. in a report on Tuesday, April 15th. Twelve equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of "Hold" and an average target price of $20.45.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Up 15.1 %

DENTSPLY SIRONA stock traded up $2.06 during midday trading on Thursday, reaching $15.74. The company's stock had a trading volume of 5,402,460 shares, compared to its average volume of 2,979,153. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market capitalization of $3.14 billion, a P/E ratio of -7.60, a PEG ratio of 1.80 and a beta of 0.92. The stock's 50-day simple moving average is $14.36 and its 200-day simple moving average is $17.75. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $28.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.13. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's revenue was down 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.42 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.07%. DENTSPLY SIRONA's payout ratio is presently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.